Renaud Schiappa

5.2k total citations · 1 hit paper
99 papers, 1.2k citations indexed

About

Renaud Schiappa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Renaud Schiappa has authored 99 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 34 papers in Pulmonary and Respiratory Medicine and 29 papers in Surgery. Recurrent topics in Renaud Schiappa's work include Breast Cancer Treatment Studies (15 papers), Colorectal and Anal Carcinomas (12 papers) and Breast Lesions and Carcinomas (12 papers). Renaud Schiappa is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Colorectal and Anal Carcinomas (12 papers) and Breast Lesions and Carcinomas (12 papers). Renaud Schiappa collaborates with scholars based in France, United Kingdom and Germany. Renaud Schiappa's co-authors include Jocelyn Gal, Nicolas Le Novère, Jean‐Antoine Girault, Jean‐Michel Hannoun‐Lévi, Emmanuel Chamorey, Marie-Eve Chand, Mathieu Gautier, D. Lam Cham Kee, Marius Ilié and Jean‐Pierre Gérard and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Renaud Schiappa

86 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial

2023 77 citations Jean‐Pierre Gérard, N. Barbet et al. profile →

Peers

Renaud Schiappa

ONCOL

PRM

SURGE

Jerry J. Jaboin United States

Seo Hee Choi South Korea

Kathrin Zaugg Switzerland

Eileen P. Connolly United States

Michael N. Corradetti United States

Rune Smaaland Norway

Jung Julie Kang United States

Carole Mathelin France

Bing Sun China

Adeel Kaiser United States

Jerry J. Jaboin United States

Renaud Schiappa

457 ×1.0

ONCOL

869 ×2.5

350 ×1.2

PRM

237 ×0.8

244 ×0.9

SURGE

Citations per year, relative to Renaud Schiappa Renaud Schiappa (= 1×) peers Jerry J. Jaboin

Countries citing papers authored by Renaud Schiappa

Since Specialization

Citations

This map shows the geographic impact of Renaud Schiappa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renaud Schiappa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renaud Schiappa more than expected).

Fields of papers citing papers by Renaud Schiappa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renaud Schiappa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renaud Schiappa. The network helps show where Renaud Schiappa may publish in the future.

Co-authorship network of co-authors of Renaud Schiappa

This figure shows the co-authorship network connecting the top 25 collaborators of Renaud Schiappa. A scholar is included among the top collaborators of Renaud Schiappa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renaud Schiappa. Renaud Schiappa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mitrea, Diana M., et al.. (2025). Organ preservation, for rectal cancer: general overview of the latest data from phase III randomized trials. Acta Oncologica. 64. 120–128.

Ebran, Nathalie, et al.. (2024). Prognostic impact of intra tumoral HPV-16 viral load in oropharyngeal squamous cell carcinomas. Oral Oncology. 159. 107082–107082. 2 indexed citations

Hofman, Véronique, Emmanuel Chamorey, Renaud Schiappa, et al.. (2024). Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non–Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging. The American Journal of Surgical Pathology. 48(9). 1072–1081. 1 indexed citations

Chamorey, Emmanuel, Jean-Marc Ferrero, Hakim Mahammedi, et al.. (2024). Long-Term Pharmacokinetic Follow-Up of Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences. 25(11). 6058–6058.

Courtinard, Coralie, Renaud Schiappa, F. Pilleul, et al.. (2024). Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-2018). SHILAP Revista de lepidopterología. 4. 100043–100043.

Dhia, Sonia Ben, N. Barbet, Renaud Schiappa, et al.. (2024). 508MO Organ preservation in early rectal adenocarcinoma: 5-year results of the randomized opera trial. Annals of Oncology. 35. S432–S432. 1 indexed citations

Schiappa, Renaud, et al.. (2023). #770 Preoperative brachytherapy of early-stage cervical cancer: results of the SFRO brachytherapy group multicenter cohort. A34.1–A34. 1 indexed citations

Benzaquen, Jonathan, Pierre‐Yves Bondiau, Josiane Otto, et al.. (2023). Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer. Radiation Oncology. 18(1). 97–97. 2 indexed citations

Gal, Jocelyn, Emmanuel Chamorey, Renaud Schiappa, et al.. (2023). Salvage vs. Primary Total Laryngectomy in Patients with Locally Advanced Laryngeal or Hypopharyngeal Carcinoma: Oncologic Outcomes and Their Predictive Factors. Journal of Clinical Medicine. 12(4). 1305–1305. 8 indexed citations

10.

Schiappa, Renaud, Dorian Culié, Jocelyn Gal, et al.. (2023). Validation of RUBY for Breast Cancer Knowledge Extraction From a Large French Electronic Medical Record System. JCO Clinical Cancer Informatics. 7(7). e2200130–e2200130. 3 indexed citations

11.

Gal, Jocelyn, O. Dassonville, Clair Vandersteen, et al.. (2023). Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules. European Journal of Endocrinology. 188(3). 249–257. 8 indexed citations

12.

Ferrero, Jean-Marc, Hakim Mahammedi, Gwénaëlle Gravis, et al.. (2023). Abigene, a Prospective, Multicentric Study of Abiraterone Acetate Pharmacogenetics in Metastatic Castration-Resistant Prostate Cancer. Pharmaceutics. 15(2). 651–651. 3 indexed citations

13.

Darcourt, Jacques, David Chardin, Véronique Bourg, et al.. (2023). Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2727–2735. 4 indexed citations

14.

Mirghani, H., Sophie El Bedoui, Anne Aupérin, et al.. (2023). Post-therapeutic surveillance of HPV-driven oropharyngeal cancers: are we ready to change our practices?. European Archives of Oto-Rhino-Laryngology. 280(8). 3811–3820. 2 indexed citations

15.

Hofman, Paul, Olivier Bordone, Emmanuel Chamorey, et al.. (2022). Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France). Frontiers in Medicine. 8. 730577–730577. 3 indexed citations

16.

Borchiellini, Delphine, Aline Guillot, Jean-Baptiste Paoli, et al.. (2021). TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer. 19(6). 501–509. 34 indexed citations

17.

Bailleux, Caroline, Emmanuel Chamorey, Renaud Schiappa, et al.. (2021). Factors Involved in Delaying Initiation of Adjuvant Chemotherapy After Breast Cancer Surgery. Clinical Breast Cancer. 22(2). 121–126. 4 indexed citations

18.

Chamorey, Emmanuel, Éric François, Marie‐Christine Etienne, et al.. (2020). DPD status and fluoropyrimidines-based treatment: high activity matters too. BMC Cancer. 20(1). 436–436. 8 indexed citations

19.

Borchiellini, Delphine, Benjamin Hoch, Vittoria Raimondi, et al.. (2019). Iron deficiency during first-line chemotherapy in metastatic cancers: a prospective epidemiological study. Supportive Care in Cancer. 28(4). 1639–1647. 10 indexed citations

20.

Culié, Dorian, R. Garrel, Julien Viotti, et al.. (2018). Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric study. European Journal of Surgical Oncology. 44(12). 1908–1913. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact